JUDITH EASTWICK EPSTEIN, M.D.
Medical Practice in Silver Spring, MD
License number
Maryland 77508
Category
Medical Practice
Type
Pediatrics
Address
Address
2
503 Robert Grant Ave., Silver Spring, MD 20852
11108 Stillwater Ave, Kensington, MD 20895
11108 Stillwater Ave, Kensington, MD 20895
Phone
(301) 252-9026
Professional information
Dr. Judith Eastwick Epstein, Silver Spring MD - MD (Doctor of Medicine)
Specialties:
Pediatric Infectious Disease Medicine
Address:
503 Robert Grant Ave, Silver Spring 20910
(301) 252-9026 (Phone)
WALTER REED ARMY MEDICAL CENTER
6900 Georgia Ave NW, Washington 20307
(202) 782-0055 (Phone), (202) 782-9364 (Fax)
(301) 252-9026 (Phone)
WALTER REED ARMY MEDICAL CENTER
6900 Georgia Ave NW, Washington 20307
(202) 782-0055 (Phone), (202) 782-9364 (Fax)
Certifications:
Pediatric Infectious Disease Medicine, 2009, Pediatrics, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Medical School
Graduated: 1990
Chldn's Hosp Of Philadelphia
Chldn's Hosp
Harvard Medical School
Graduated: 1990
Chldn's Hosp Of Philadelphia
Chldn's Hosp
Judith Eastwick E Epstein, Silver Spring MD
Specialties:
Pediatrician
Address:
503 Robert Grant Ave, Silver Spring, MD 20910
Education:
Harvard Medical School - Doctor of Medicine
Children's Hospital Boston - Fellowship - Research
Children's Hospital Boston - Fellowship - Research
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)
Methods For Vaccinating Against Malaria
US Patent:
8232255, Jul 31, 2012
Filed:
Oct 22, 2003
Appl. No.:
10/532081
Inventors:
Stephen L. Hoffman - Gaithersburg MD, US
Ruobing Wang - Potomac MD, US
Judith E. Epstein - Kensington MD, US
Joseph D. Cohen - Brussels, BE
Ruobing Wang - Potomac MD, US
Judith E. Epstein - Kensington MD, US
Joseph D. Cohen - Brussels, BE
Assignee:
GlaxoSmithKline Biologicals S.A. - Rixensart
The United States of America as represented by the Secretary of the Navy - Washington DC
The United States of America as represented by the Secretary of the Navy - Washington DC
International Classification:
A61K 39/00, A61K 48/00
US Classification:
514 44R, 4241841
Abstract:
The invention pertains to methods for protecting against malaria infection by vaccination. The method of the invention involves priming an anti-malaria immune response with a DNA-based vaccine and boosting that response with a protein-based a vaccine. The method of the invention also relates to broadening the resulting immune response by boosting with a protein-based vaccine.